{
  "company": {
    "name": "Enodia Therapeutics",
    "website": "https://enodiatx.com/",
    "record": "https://startuphistory.org/c/enodiatx.com"
  },
  "status": null,
  "history_since": "2026-11-12T11:19:12.800Z",
  "baseline": {
    "snapshot_id": "34bfa7c7084d17f9cbfa3d5f430aeb91959969532e252fcf810a7f1376810eef",
    "observed_at": "2026-11-12T11:19:12.800Z",
    "headline": "Targeting disease at its source: protein degradation at the point of synthesis",
    "description": "Enodia Therapeutics pioneers targeted protein degradation at the Sec61 translocon, developing small-molecule therapies for inflammatory and autoimmune diseases.",
    "evidence": "https://www.enodiatx.com/",
    "evidence_kind": "live_capture",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-12T11:19:12.800Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-12T11:19:12.800Z",
      "variants": [
        {
          "headline": "Targeting disease at its source: protein degradation at the point of synthesis",
          "subhead": "Enodia Therapeutics pioneers targeted protein degradation at the Sec61 translocon, developing small-molecule therapies for inflammatory and autoimmune diseases.",
          "observed_at": "2026-11-12T11:19:12.800Z",
          "evidence": "https://www.enodiatx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Targeting disease at its source: protein degradation at the point of synthesis",
      "subhead": "Enodia Therapeutics pioneers targeted protein degradation at the Sec61 translocon, developing small-molecule therapies for inflammatory and autoimmune diseases.",
      "from": "2026-11-12T11:19:12.800Z",
      "to": "2026-11-12T11:19:12.800Z",
      "captures": 1,
      "evidence": "https://www.enodiatx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-12T11:19:12.800Z"
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Switch Therapeutics",
      "record": "https://startuphistory.org/c/switchthera.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "Noema Pharma",
      "record": "https://startuphistory.org/c/noemapharma.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "Mediar Therapeutics",
      "record": "https://startuphistory.org/c/mediartx.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "Athira Pharma",
      "record": "https://startuphistory.org/c/athira.com",
      "basis": "description_similarity",
      "category": null
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Enodia Therapeutics” company record, https://startuphistory.org/c/enodiatx.com"
}